ReachRxResearch
Home
Research
Sign Up
Congenital TORCH Infections and Neurodevelopmental Outcomes
Back to Research Hub
  1. Home
  2. Research Hub
  3. Congenital TORCH Infections and Neurodev…

Congenital TORCH Infections and Neurodevelopmental Outcomes

JAMA Pediatrics·September 21
PediatricsPractice changingAttention-Deficit/Hyperactivity DisorderAutism Spectrum DisorderCongenital CytomegalovirusCongenital TORCH InfectionIntellectual DisabilityPopulation-Based Cohort StudyInfectious Disease EpidemiologyAdolescentChildPediatric

Summary

View source

What was studied

This nationwide Swedish cohort study (n=3,666,002 births, 1987–2021) examined whether clinically diagnosed congenital TORCH infections (CMV, toxoplasmosis, rubella, HSV, syphilis; n=975 exposed) were independently associated with intellectual disability (ID), autism, ADHD, OCD, tic disorders, nonaffective psychosis, and school grades at age 16, using both population-level Cox regression and sibling-comparison models to control for familial confounding.

Key findings

Congenital TORCH infection was strongly associated with ID (HR 7.22; 95% CI 6.14–8.49) and autism (HR 3.10; 95% CI 2.55–3.76); sibling comparisons yielded similar or larger estimates (ID: HR 11.28; autism: HR 3.19), ruling out shared familial factors as the explanation. Risk scaled with ID severity (mild HR 3.01 to severe/profound HR 23.51), and exposed individuals scored 1.50 points lower on standardized school grades. ADHD associations attenuated in sibling analyses; OCD showed no consistent association. CMV drove the largest signal (autism HR 4.57; ID HR 10.84 in adjusted models).

Study limitations

TORCH diagnoses came from clinical registers, likely undercounting mild or asymptomatic cases (ascertainment bias). Only 975 exposed individuals were identified over 35 years, limiting power for pathogen-specific and rare-outcome analyses. Diagnostic methods changed across the study period (culture pre-1993, then PCR), introducing temporal heterogeneity.

Clinical implications

Clinicians should counsel that congenital TORCH infections — especially CMV — carry a substantially elevated risk of ID and autism that persists after accounting for family background, reinforcing the importance of antenatal screening and preventive strategies (e.g., CMV hygiene counseling, rubella vaccination). Children diagnosed with congenital TORCH should be followed proactively for neurodevelopmental disorders, including academic difficulties even in the absence of a formal diagnosis.

Caveats

  • Findings reflect the Swedish healthcare and diagnostic context; generalizability to settings with different TORCH prevalence, screening practices, or healthcare access may be limited
  • Register-based TORCH ascertainment captures only clinically diagnosed cases, so milder or asymptomatic infections — which may still carry neurodevelopmental risk — are missed, potentially underestimating the true burden
  • The TORCH-exposed group (n=975) is small relative to the full cohort, limiting statistical power for pathogen-specific analyses and rare outcomes; several cells were suppressed (n<5)

Related Questions

Explore related topics

What is the risk of autism and intellectual disability after congenital CMV infection?How effective is antenatal CMV screening and hygiene counseling in preventing congenital infection?Which neurodevelopmental follow-up protocols are recommended for infants with confirmed congenital TORCH infections?

Publication Details

Year
2026
Journal
JAMA Pediatrics
Sample Size
n=3,666,002
Source
View article
Keep scrolling
More content below.
Up Next